Uriage Roséliane Anti-Redness Cream Face Cream 40ml

Uriage Roséliane Anti-Redness Cream Face Cream 40ml

Marsoni

M251S

$29.04

Get it in 3 business days with 1 day shipping. Friday, May 29

Uriage Roséliane Anti-Redness Cream Face Cream 40mlUriage Rosliane Anti Redness Cream 40ml is a premium face cream of Uriage brand. A rich and non greasy cream that inhibits the key factors triggering couperose rosacea, protects the skin's vascular system, and limits aggravating factors. Upon application, comfort is immediately restored to the skin, leaving it soft, perfectly moisturised, and soothed. Repairs and Strengthens the Cutaneous Barrier. Rich in Uriage Thermal Water with moisturising and

Easy Shipping

Quick Dispatch:

Your Uriage Roséliane Anti-Redness Cream Face Cream 40ml orders ship within 1-2 business days.

Delivery Options:

Standard: 3-7 business days
Fast: 2-3 business days
Express: 1-2 business days

Order Tracking:

You'll receive a tracking link by email once your Uriage Roséliane Anti-Redness Cream Face Cream 40ml ships.

Need Help?
Questions about Uriage Roséliane Anti-Redness Cream Face Cream 40ml, sizing, or delivery? We're just an email away.

Live Shipping Estimates:
Enter your location at checkout to see available shipping methods and costs for Uriage Roséliane Anti-Redness Cream Face Cream 40ml in your area.

Get Shipping Estimates

Country Zip/Postal Code

Exchange/Return Notes

We offer a 30-day return/exchange service after receiving.
Final sale items are not eligible for returns or exchanges.
To process your return/exchange, please contact us at [email protected]
Please click here for more details>>> Return & Exchange Policy

Great size. Its medium/small. Not cheap looking which is great. It has space for our phone charger, a drink and a small lamp. (The one in the photo is too big) My fiance put it together within an hour, the instructions were easy to understand. It does not wobble but we do have it on wood. Its not heavy so it does slide around.

WAS THIS REVIEW HELPFUL?YesReportShare

Reviewed in the United States on March 13, 2026